Pfizer investing $120M to boost US COVID-19 treatment production
This post was originally published on this sitePfizer announced Monday that it is investing $120 million to boost production of its COVID-19 treatment pills in the United States. The move will create more than 250 jobs at its plant in Kalamazoo, Mich., the company said, as it looks to increase...
Biden administration secures 20 million courses of Covid-19 antiviral pill
This post was originally published on this siteThe Biden administration has secured the purchase of 20 million treatment courses of Paxlovid, Pfizer’s antiviral Covid-19 pill, a senior administration official told CNN on Monday.
Pfizer Starts Testing Its Covid-19 Pill in Children
This post was originally published on this siteThe drugmaker expects results from its study of the drug Paxlovid in high-risk children by the end of the year.
Pfizer sees Covid-19 drug sales topping $50 billion in 2022
This post was originally published on this site Pfizer forecast more than $50 billion in 2022 sales for its Covid-19 vaccine and therapeutic on Tuesday as the pharmaceutical giant reported a more than doubling of annual profits on strong sales of its innoculation. Pfizer, whose vaccinee developed with German company...
Pfizer and BioNTech announce plans to test omicron-specific COVID-19 vaccine in adult trials
This post was originally published on this sitePfizer and BioNTech will conduct three simultaneous trials in adults to determine if an omicron-specific vaccine is more effective than current shots.
COVID–19 Vaccine Accountability Act would remove near-total legal immunity for Pfizer, Moderna…
This post was originally published on this siteCOVID–19 Vaccine Accountability Act would remove near-total legal immunity for Pfizer, Moderna, Johnson & Johnson Rep. Scott Perry (R-PA10) Should Americans be able to sue the companies which make the COVID-19 vaccine? Context During a public health emergency, the federal government wants to remove any barriers...
CDC Panel Considers Pfizer Boosters for 12- to 15-Year-Olds
This post was originally published on this siteAdolescents could gain access to the shots for the first time as the Omicron variant spreads through communities and threatens to disrupt schools trying to stay open.
Pfizer antiviral reduces hospitalization, death among high-risk people by 89%, study shows: COVID-19 updates
This post was originally published on this siteA study found that Pfizer’s antiviral drug, Paxlovid, reduced hospitalization or death among high-risk people by 89%. More COVID-19 updates.
‘Our best defense’: Pfizer says third dose of its COVID vaccine protects against omicron
This post was originally published on this siteA third dose of the Pfizer-BioNTech vaccine appears to be as effective against omicron as two doses were against the original variant.
Pfizer Says Vaccine Loses Effectiveness Against Omicron
This post was originally published on this sitePfizer and BioNTech said that a third dose of their Covid-19 vaccine neutralized the Omicron variant in lab tests but that the two-dose regimen was significantly less effective at blocking the virus.
- 1
- 2
